Cargando…
Cross communication of diet-microbiome-immune interactions in cancer immunotherapy
Simpson et al. have highlighted a diet-driven microbiome community, which paves the way for landmark therapeutic avenues for facilitating efficacy and minimizing immune-related adverse events during neoadjuvant immune checkpoint inhibitor treatment in melanoma patients. This innovative attempt inspi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729813/ https://www.ncbi.nlm.nih.gov/pubmed/36384089 http://dx.doi.org/10.1016/j.xcrm.2022.100806 |
| _version_ | 1784845552146448384 |
|---|---|
| author | Zhou, Cheng-Bei Fang, Jing-Yuan |
| author_facet | Zhou, Cheng-Bei Fang, Jing-Yuan |
| author_sort | Zhou, Cheng-Bei |
| collection | PubMed |
| description | Simpson et al. have highlighted a diet-driven microbiome community, which paves the way for landmark therapeutic avenues for facilitating efficacy and minimizing immune-related adverse events during neoadjuvant immune checkpoint inhibitor treatment in melanoma patients. This innovative attempt inspires application of the diet-microbiome-immune interaction axis to maximize clinical benefits. |
| format | Online Article Text |
| id | pubmed-9729813 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97298132022-12-09 Cross communication of diet-microbiome-immune interactions in cancer immunotherapy Zhou, Cheng-Bei Fang, Jing-Yuan Cell Rep Med Spotlight Simpson et al. have highlighted a diet-driven microbiome community, which paves the way for landmark therapeutic avenues for facilitating efficacy and minimizing immune-related adverse events during neoadjuvant immune checkpoint inhibitor treatment in melanoma patients. This innovative attempt inspires application of the diet-microbiome-immune interaction axis to maximize clinical benefits. Elsevier 2022-11-15 /pmc/articles/PMC9729813/ /pubmed/36384089 http://dx.doi.org/10.1016/j.xcrm.2022.100806 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Spotlight Zhou, Cheng-Bei Fang, Jing-Yuan Cross communication of diet-microbiome-immune interactions in cancer immunotherapy |
| title | Cross communication of diet-microbiome-immune interactions in cancer immunotherapy |
| title_full | Cross communication of diet-microbiome-immune interactions in cancer immunotherapy |
| title_fullStr | Cross communication of diet-microbiome-immune interactions in cancer immunotherapy |
| title_full_unstemmed | Cross communication of diet-microbiome-immune interactions in cancer immunotherapy |
| title_short | Cross communication of diet-microbiome-immune interactions in cancer immunotherapy |
| title_sort | cross communication of diet-microbiome-immune interactions in cancer immunotherapy |
| topic | Spotlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729813/ https://www.ncbi.nlm.nih.gov/pubmed/36384089 http://dx.doi.org/10.1016/j.xcrm.2022.100806 |
| work_keys_str_mv | AT zhouchengbei crosscommunicationofdietmicrobiomeimmuneinteractionsincancerimmunotherapy AT fangjingyuan crosscommunicationofdietmicrobiomeimmuneinteractionsincancerimmunotherapy |